THE ROLE OF A STRUCTURED NONADMISSION‐BASED TRANSIENT ISCHEMIC ATTACK PROTOCOL IN REDUCING LENGTH OF STAY
Internal Medicine Journal · 2022
among recipients of chemotherapy compared with targeted therapy.Patients on immunotherapy had the lowest antibody level, although the small sample size limits definitive conclusion in this subgroup.Reassuringly, a rise in anti-spike antibody occurred after the 3rd primary dose in cancer patients, surpassing the level among controls prior to receipt of booster vaccination.